US Biosimilar Market

Artificial Intelligence Meets Pharmacovigilance

AI in R&D Platforms

Resilient by Design

Clinical Trial Modernization - Technological, Operational, and Regulatory Advances

EDITORIAL SECTION

STRATEGY

Strategic Positioning for M&A

The biotechnology sector is characterised by a constant influx of small highly specialised companies

RESEARCH DEVELOPMENT

Cytiva Laboratory capsule filters

Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling

CLINICAL TRIALS

Virtual Clinical Trials

Virtual digital and decentralized are all descriptions of the novel ways that using technology changes

Bio Pharma

Biosimilars and Biobetters

Biosimilars are biologic medical products that are essentially identical to an original product manufactured

MANUFACTURING

Transformative Convergence of AI in Pharmaceutical Manufacturing

The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by

Information Technology

Transformative Impact of Artificial Intelligence on Clinical Trials

Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries

EXPERT Talk

Sustainable Innovation in Biopharma: Aligning Therapeutic Progress with Environmental Responsibility

To genuinely align RD with environmental responsibility biopharma organisations must embrace systemic structural and cultural transformations

Advisory Board

Victor M. Diaz Perez

Kishore Hotha

Joab Williamson

Scott M. Wheelwright

Tamara Miller

Juris Hmelnickis

David Contorno

Svetlana Busiguina

Eiman Shafa

Nigel Cryer FRSC

Hector Alejandro Andonie

Josipa Ljubicic

KNOWLEDGE BANK

Articles

Pharma Display Advertising: Boost Leads & Webinar Registrations Instantly

With the ever growing competition in the pharmaceutical industry firms are always trying to find viable methods of accessing decisionmakers creating qualified leads and marketing thought leadership opportunities eg webinars The old ways of outreach are no longer effective in the digitalfirst environment where the executives of healthcare the researchers of pharmaceuticals and the leaders of the in...

Techno Trends

Shield Therapeutics Receives FDA Approval for ACCRUFeR® in Pediatric Patients

Shield Therapeutics plc has announced that the US Food and Drug Administration FDA has approved ACCRUFeR ferric maltol for the treatment of iron deficiency in children aged years and older

Projects

Johnson & Johnson Invests Over $1 Billion in New Cell Therapy Manufacturing Facility

Johnson Johnson has announced plans to invest more than billion in a nextgeneration cell therapy manufacturing facility in Montgomery County Pennsylvania The new site will expand the companys manufacturing capacity

Research Insights

Controllable protein design via autoregressive direct coupling analysis conditioned on principal components

We present FeatureDCA a statistical framework for protein sequence modeling and generation that extends Direct Coupling Analysis DCA

White Papers

Accelerating In-Vitro Antibody Discovery with Artificial Intelligence

Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities

press releasesRead more...

SK pharmteco Announces Successful Completion of FDA Inspection of Small Molecule Production Facility in Rapport, Texas

SK Pharmteco announced today that regulatory inspections of its North American small molecule production facility in La Porte Texas have been successfully completed

Biocom and Octane Announce Strategic Partnership to Accelerate Innovation Across California’s Life Science and Medtech Ecosystems

Biocom the largest life science membership association representing companies across California and major life science markets and Octane a leading accelerator and innovation platform for technology and medtech companies

Sun Pharma Announces US FDA Acceptance of Supplemental Biologics License (sBLA) Application for ILUMYA® (tildrakizumab-asmn) for the Treatment of Adults with Active Psoriatic Arthritis

Sun Pharmaceutical Industries Limited Reuters SUNBO Bloomberg SUNP IN NSE SUNPHARMA BSE Sun Pharma and includes its subsidiaries andor associated companies announced that the US Food and Drug Administration

IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences

IQVIA Holdings Inc NYSEIQV a leading global provider of clinical research services commercial insights and healthcare intelligence today announced at NVIDIA GTC the launch of IQVIAai a unified agentic AI platform